Using Kaplan–Meier survival analyses, no significant association was found between the presence of KRAS mutations in tumor tissue and patient’s prognosis in terms of both PFS (p = 0.532) and OS (p = 0.263) (Figure 3). Here, KRAS is linked to neoplasm.